Safety of Tralokinumab for the Treatment of Atopic Dermatitis in Patients with Up to 4.5 Years of Treatment: An Updated Integrated Analysis of Eight Clinical Trials . (2024). SKIN The Journal of Cutaneous Medicine, 8(2), s375. https://doi.org/10.25251/skin.8.supp.375